Skip to content
Industrial Relations, Medical Health Aged Care

Monash Experts: Possible engineered stone ban

Monash University 3 mins read

A decision could be made today on whether Australia will be the first country in the world to ban engineered stone due to the risk of silicosis to workers, during a meeting of work, health and safety ministers. 

 

Silicosis is a preventable ‘occupational lung disease’ that is caused by breathing crystalline silica dust, causing lung inflammation and fibrosis. There is no cure. 

 

Available to comment: 

 

Associate Professor Jane Bourke, Head of Respiratory Pharmacology, Monash Biomedicine Discovery Institute, and Fellow of the The Thoracic Society of Australia and New Zealand.

Contact details: +61 3 9903 4840 or media@monash.edu  

Twitter/X: @jane_bourke_phd
Read more of Associate Professor Bourke’s commentary at Monash Lens, read more about her achievements on Monash News and visit the Bourke Lab website for more information about her research.

 

  • More than 20 years’ research on finding new treatments for chronic lung diseases
  • Her current project leading a research program into “Establishing a novel human model for anti-fibrotic drug screening in silicosis” is funded by the Dust Diseases Board/iCARE NSW

The following can be attributed to Associate Professor Bourke:


“Advocacy for the banning of engineered stone from all health sectors, including clinicians and medical researchers from Monash University, is based on unequivocal evidence that there is no safe level of exposure to silica dust – it’s taken too long for this action to be taken to protect workers from silicosis.

 

“Ongoing monitoring of the estimated 10,000 Australians currently in the engineered stone workforce will still be required as more cases emerge due to prior exposure to this dangerous dust. 

 

“For the hundreds of workers already diagnosed with this totally preventable but currently incurable disease, a ban would come too late – but at least further cases may be reduced or prevented.

 

“Engineered stone benchtops have become so popular in Australia, it’s critical that we take the lead with a world-first ban. We must value lives ahead of industry profits as we continue our research to understand how this devastating disease damages the lungs and try to find effective treatments for those already affected.” 

 

Dr Ryan Hoy, Respiratory and sleep physician and Senior Research Fellow at the Monash Centre for Occupational and Environmental Health, within the School of Public Health and Preventive Medicine.

Contact +61 3 9903 4840 or media@monash.edu

Read more of Dr Hoy’s commentary at Monash Lens 

 

  • More than 15 years experience treating patients with occupational lung disease. 
  • Head of the Occupational Respiratory Clinic at the Alfred Hospital
  • Chief investigator of the world’s largest study of stone benchtop industry workers, which has identified that 117 out of 414 (28.2 per cent) of Victorian stone benchtop industry workers screened by CT have silicosis.  

The following can be attributed to Dr Hoy:


“A decision by Australian governments to ban engineered stone would be a highly significant moment in the response to the worst outbreak of occupational lung disease in generations. Elimination of engineered stone is clearly the most effective means to protect workers in this industry.

 

“Over 600 Australian stone benchtop industry workers have already been diagnosed with silicosis, and due to high levels of silica exposure, thousands more will remain at risk of disease for decades to come. 

 

“Urgent government funding is required to provide free ongoing health monitoring for workers who have been exposed to dangerous levels of silica, and to find new effective treatments for silicosis. 

 

“No one should contract a disease from going to work. Over 600 workers with silicosis caused by working in the stone benchtop industry is completely unacceptable. Governments must learn from this avoidable epidemic of silicosis. We need to do much better to identify new and emerging hazards at workplaces before people become sick.”

For more Monash media stories visit our news & events site: monash.edu/news
For any other topics on which you may be seeking expert comment, contact the Monash University Media Unit on +61 3 9903 4840 or media@monash.edu

 

 

More from this category

  • Medical Health Aged Care
  • 27/12/2024
  • 17:11
Takeda Pharmaceutical Company Limited

Takeda Announces Approval of HYQVIA® 10% S.C. (Subcutaneous) Injection Set in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia

HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] is the First and Only Facilitated Subcutaneous Immunoglobulin (fSCIG) Approved in Japan for Agammaglobulinemia…

  • Contains:
  • Medical Health Aged Care
  • 23/12/2024
  • 22:11
BeiGene, Ltd.

BeiGene to Change Nasdaq Ticker Symbol to “ONC” on January 2; Present at 43rd Annual J.P. Morgan Healthcare Conference

SAN MATEO, Calif.–BUSINESS WIRE– BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne…

  • Contains:
  • Medical Health Aged Care
  • 23/12/2024
  • 12:57
Royal Australian College of GPs

RACGP: Look after your mental health this holiday season

The Royal Australian College of GPs (RACGP) has urged Australians to look after themselves and their loved ones this holiday season. College President, Dr Michael Wright, said that reaching out and helping others can make all the difference. “The holiday season can be a challenging time for many Australians,” he said. “Many of us can have family and relationship pressures, financial pressures may become more obvious, and isolation and loneliness can be at their worst this time of year too. So, during this festive season please try to look after yourself and the people in your life. It can be…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.